Although the group recognized the apparent risk, it declined to recommend adoption of the warnings stating a worry they could scare epilepsy patients away from taking these medications.
Unfortunately, epilepsy is not the only condition treated with this category of medication. As Wired Magazine Science writer Brandon Keim wisely points out, 90% of sales of Pfizer's drug Neurontin were made to people using it for something other than epilepsy, such as migraines.
Migraineurs may have a different interest in seeing black box warnings on antiseizure medications. This is not to say that no rational migraineur would choose a medication in this category for migraine prevention, of course. However, the prevalence of depression among migraineurs makes it all the more important to be aware of the tendency of a medication to increase suicidal thoughts.
FDA Review of Studies on Suicide & Seizure Meds Released
Follow Up: Antiepileptic Drugs and Suicidal Thoughts
Antiepileptic Meds Related to Suicidal Ideation
FDA Holds Hearings on Epilepsy Drug Suicide Risk
US Advisers Reject Strong Epilepsy Drug Warning
Technorati Tags: suicide, news, prevention, medication, depression, migraines, chronic illness, health, somebody heal me
Subscribe to the Somebody Heal Me feed: Subscribe in a reader or subscribe by e-mail.
Content by Diana E. Lee.